Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Neijt

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
European Journal of Cancer & Clinical Oncology|September 1, 1989
The effect of three dose levels of ICS 205-930 (a selective 5HT-3 antagonist) on cisplatin-induced nausea and vomitingH Seinen, B A Zonnenberg, P Tjia, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk)) as main objectivesE E Voest, J C van Houwelingen, J P Neijt
Lancet (London, England)|May 14, 1983
JM8 (cisplatin analogue) alone for previously untreated advanced ovarian carcinomaJ P Neijt, J W Nortier, C P Vendrik, et al.
Cancer Research|August 1, 1990
Comparison of the predictive power of different prognostic indices for overall survival in patients with advanced ovarian carcinomaB Lund, P Williamson, H C van Houwelingen, et al.
British Journal of Cancer|December 1, 1990
Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom ChecklistJ C de Haes, F C van Knippenberg, J P Neijt
European Journal of Pharmacology|March 16, 1993
The ACTH-(4-9) analog, ORG 2766, prevents taxol-induced neuropathy in ratsF P Hamers, C Pette, J P Neijt, et al.
Anticancer Research|July 1, 1993
The difference between benign and malignant tumours explained with the 4-mutation paradigm for carcinogenesisJ W Koten, J P Neijt, B A Zonnenberg, et al.
Experimental Neurology|September 1, 1987
Org.2766 protects from cisplatin-induced neurotoxicity in ratsP de Koning, J P Neijt, F G Jennekens, et al.
The Netherlands Journal of Medicine|April 1, 1988
Diagnosis and treatment in metastatic adenocarcinoma of unknown primary tumourB G Taal, C H Veenhof, G H Blijham, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 14, 1987
[The treatment of pancreatic carcinoma with cytostatic agents]J P Neijt, G H Blijham, B G Taal, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
European Journal of Cancer & Clinical Oncology|September 1, 1989
The effect of three dose levels of ICS 205-930 (a selective 5HT-3 antagonist) on cisplatin-induced nausea and vomitingH Seinen, B A Zonnenberg, P Tjia, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk)) as main objectivesE E Voest, J C van Houwelingen, J P Neijt
Lancet (London, England)|May 14, 1983
JM8 (cisplatin analogue) alone for previously untreated advanced ovarian carcinomaJ P Neijt, J W Nortier, C P Vendrik, et al.
Cancer Research|August 1, 1990
Comparison of the predictive power of different prognostic indices for overall survival in patients with advanced ovarian carcinomaB Lund, P Williamson, H C van Houwelingen, et al.
British Journal of Cancer|December 1, 1990
Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom ChecklistJ C de Haes, F C van Knippenberg, J P Neijt
European Journal of Pharmacology|March 16, 1993
The ACTH-(4-9) analog, ORG 2766, prevents taxol-induced neuropathy in ratsF P Hamers, C Pette, J P Neijt, et al.
Anticancer Research|July 1, 1993
The difference between benign and malignant tumours explained with the 4-mutation paradigm for carcinogenesisJ W Koten, J P Neijt, B A Zonnenberg, et al.
Experimental Neurology|September 1, 1987
Org.2766 protects from cisplatin-induced neurotoxicity in ratsP de Koning, J P Neijt, F G Jennekens, et al.
The Netherlands Journal of Medicine|April 1, 1988
Diagnosis and treatment in metastatic adenocarcinoma of unknown primary tumourB G Taal, C H Veenhof, G H Blijham, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 14, 1987
[The treatment of pancreatic carcinoma with cytostatic agents]J P Neijt, G H Blijham, B G Taal, et al.
Pageof 10